Randomized, double blind, dose-response trial across four oral doses of dolasetron for the prevention of acute emesis after moderately emetogenic chemotherapy. Oral Dolasetron Dose-Response Study Group (Q73155453)
Jump to navigation
Jump to search
scientific article published on 01 March 1997
Language | Label | Description | Also known as |
---|---|---|---|
English | Randomized, double blind, dose-response trial across four oral doses of dolasetron for the prevention of acute emesis after moderately emetogenic chemotherapy. Oral Dolasetron Dose-Response Study Group |
scientific article published on 01 March 1997 |
Statements
Randomized, double blind, dose-response trial across four oral doses of dolasetron for the prevention of acute emesis after moderately emetogenic chemotherapy. Oral Dolasetron Dose-Response Study Group (English)
Rubenstein EB
Gralla RJ
Hainsworth JD
Hesketh PJ
Grote TH
Modiano MR
Khojasteh A
Kalman LA
Benedict CR